VALVOSOFT®, the First Non-Invasive Treatment for Severe Symptomatic Aortic Stenosis (sSAS) From Cardiawave Receives CE Marking

Non-invasive ultrasound therapy for aortic stenosis gains CE mark

Cardiawave has received CE certification for Valvosoft, its non-invasive therapeutic alternative to treat severe symptomatic aortic stenosis. Valvosoft is designed to non-invasively restore leaflet mobility in a stenotic aortic valve and widen the valve opening to relieve patient heart failure symptoms. High-intensity focused ultrasound waves micro-fracture calcification embedded in aortic valve leaflets without damaging tissue. The treatment is…